30 Most Overweight and Obese Cities in the U.S. In 2023

In This Article:

In this article, we will be taking a look at the 30 most overweight and obese cities in the U.S. in 2023. To skip our detailed analysis, you can go directly to see the 5 most overweight and obese cities in the U.S. in 2023.

Obesity in the U.S. is one of the biggest issues facing the country right now, and a consistently growing one. Drastic changes in lifestyles in the past several decades have resulted in a more sedentary living while the consumption of processed foods is consistently increasing. Nearly a third of adults are overweight in the U.S. and over 40% are considered to be obese. Severe obesity is still less prevalent but a growing concern with over 9% of adults in the country being severely obese. While the percentages of overweight and obese children are still not as high, the most overweight and obese cities in the U.S. in 2023 face a major issue there as well.

30 Most Overweight and Obese Cities in the U.S. In 2023
30 Most Overweight and Obese Cities in the U.S. In 2023

Copyright: ximagination / 123RF Stock Photo

Diet / Weight Loss Industry and its Outlook

In response to consistently increasing obesity, many industries have propped up to cater to an ever-growing customer base, and the diet industry has grown massively in a short period of time. While dieting or eating healthy is a requisite part of any active lifestyle, many extreme diet fads continue to pop us as well, which aim to reduce a significant amount of weight in a short period of time. On the other hand, many diet companies, including some of the biggest diet companies in the world such as Medifast, Inc. (NYSE:MED), promote a more sustainable nutrition program and supplements to facilitate weight loss.  Despite growing demand for weight loss and nutrition companies, especially in the most overweight and obese cities in the U.S. in 2023, Medifast, Inc. (NYSE:MED) has seen its share price fall drastically by over 30% YTD 2023, due to low P/E ratios and in May 2023, reported an EPS decline of 9%, contributing further to investor losses.

This has been partly attributable to a changing landscape and companies having to reassess their long-term strategy, which was called out by Medifast, Inc. (NYSE:MED) in its Q2 2023 earnings call, stating " As we have mentioned previously, the market has experienced some significant shifts in the last year, caused in part by changes in the macroeconomic and competitive environments. In both areas, shifts have impacted the nature of the demand and demand creation, and caused Medifast and other companies to reassess drivers for long-term growth. With that in mind, we have now embarked on an aggressive path to make meaningful investments to evolve our business model for growth in the new environment. Going forward, we will use our coach-guided habit-based lifestyle program and products to extend beyond the $8 billion structured weight loss market, where we are a major player. To be clear, the traditional weight loss management sector will remain important, and we will continue to implement plans, designed to increase our share of this dynamic segment, including extending our offer to better integrate with the emerging trends in medically supported weight loss and continuing to broaden our demographic focus to the Hispanic market, which will lay the groundwork for future expansion into Latin America. However, at the same time, we are also moving forward with some exciting new initiatives, which we expect will be drivers for future performance, focused on monetizing multiple healthy habits."